1
Adjuvant Dabrafenib (GSK2118436) in Patients With Surgically Resected AJCC Stage IIIC Melanoma Characterized by a BRAFV600E/K Mutation
Condition(s):MelanomaLast Updated:May 26, 2020Completed
Stage IIIC Melanoma: 168 Clinical Trials, Page 1 of 17
Hide Studies Not Open or Pending
2
Study of Denileukin Diftitox in Patients With Stage IIIC and Stage IV Melanoma
Condition(s):Stage IIIC Melanoma; Stage IV MelanomaLast Updated:March 5, 2019Completed
3
Vaccine Combining Multiple Class I Peptides and Montanide ISA 51VG With Escalating Doses of Anti-PD-1 Antibody Nivolumab or Ipilimumab With Nivolumab For Patients With Resected Stages IIIC/ IV Melanoma
Condition(s):Melanoma (Skin)Last Updated:January 5, 2021Active, not recruiting
4
RO4929097 in Treating Patients With Stage IIIB, Stage IIIC, or Stage IV Melanoma That Can Be Removed by Surgery
Condition(s):Stage IIIB Melanoma; Stage IIIC Melanoma; Stage IV MelanomaLast Updated:January 31, 2013Withdrawn
5
Dinaciclib in Treating Patients With Stage III-IV Melanoma
Condition(s):Stage IIIB Melanoma; Stage IIIC Melanoma; Stage IV MelanomaLast Updated:April 4, 2017Terminated
6
Ex Vivo-Activated Lymph Node Lymphocytes in Treating Patients With Stage IIIC-IV Melanoma
Condition(s):Stage IIIC Skin Melanoma; Stage IV MelanomaLast Updated:December 6, 2018Terminated
7
A Clinical Trial: Adjuvant Low-dose Ipilimumab + Nivolumab After Resection of Melanoma Macrometastases
Condition(s):Stage IIIC Skin Melanoma; Stage IV Skin MelanomaLast Updated:January 24, 2019Completed
8
Aurora A Kinase Inhibitor MLN8237 in Treating Patients With Unresectable Stage III-IV Melanoma
Condition(s):Recurrent Melanoma; Stage IIIc Melanoma; Stage IV MelanomaLast Updated:May 30, 2016Terminated
9
A Study of Transgenic Lymphocyte Immunization (TLI) Against Telomerase in Subjects With Stage III Melanoma
Condition(s):Stage IIIB Skin Melanoma; Stage IIIC Skin MelanomaLast Updated:February 13, 2012Unknown status
10
Tissue and Blood Biomarkers From Patients With Stage III or Stage IV Melanoma Treated With Ipilimumab With or Without Sargramostim
Condition(s):Melanoma (Skin)Last Updated:May 17, 2017Completed